Table 1 Descriptive summary of samples
highLDL highTG | Control (LDL ≤ 100 and TG ≤ 100, n=681) | Case ( LDL ≥ 130 and TG ≥ 180, n=545) | ||||||
|---|---|---|---|---|---|---|---|---|
Area/sex n=individual | Ansung n=381 | Ansan n=300 | Male n=233 | Female n=458 | Ansung n=205 | Ansan n=340 | Male n=288 | Female n=257 |
AGE | 52.6 ± 9.45 | 45.7 ± 5.88 | 54.1 ± 9.34 | 47.3 ± 7.56 | 56.6 ± 8.20 | 50.1 ± 8.19 | 49.6 ± 7.99 | 55.8 ± 8.45 |
BMI | 22.7 ± 3.06 | 23.2 ± 2.80 | 21.8 ± 2.71 | 23.4 ± 2.94 | 26.0 ± 2.84 | 25.9 ± 2.71 | 25.5 ± 2.58 | 26.4 ± 2.89 |
WHR | 0.88 ± 0.06 | 0.79 ± 0.07 | 0.87 ± 0.06 | 0.83 ± 0.08 | 0.95 ± 0.05 | 0.87 ± 0.05 | 0.90 ± 0.05 | 0.90 ± 0.08 |
TCHL | 148 ± 18.3 | 151 ± 15.61 | 149 ± 17.8 | 150 ± 16.9 | 240 ± 22.3 | 243 ± 24.6 | 242 ± 22.8 | 242 ± 24.9 |
HDL | 50.3 ± 10.5 | 50.0 ± 10.5 | 51.0 ± 12.0 | 49.8 ± 9.70 | 42.4 ± 8.56 | 42.5 ± 7.66 | 42.2 ± 7.55 | 43.0 ± 8.48 |
LDL | 81.8 ± 14.8 | 85.1 ± 11.7 | 81.6 ± 14.5 | 84.1 ± 13.1 | 150 ± 16.8 | 155 ± 20.9 | 152 ± 18.6 | 153 ± 20.7 |
TG | 81.4 ± 13.4 | 81.0 ± 12.4 | 80.9 ± 14.5 | 81.4 ± 12.2 | 238 ± 51.7 | 231 ± 49.0 | 237 ± 52.3 | 230 ± 47.3 |
highLDL | Control (LDL ≤ 100, n=2215) | Case (LDL ≥ 130, n=2271) | ||||||
Area/sex n=individual | Ansung n=1403 | Ansan n=812 | Male n=1024 | Female n=1191 | Ansung n=919 | Ansan n=1352 | Male n=1044 | Female n=1227 |
LDL | 79.6 ± 16.6 | 84.1 ± 12.4 | 79.2 ± 17.3 | 83.0 ± 13.2 | 151 ± 17.9 | 155 ± 20.9 | 154 ± 19.5 | 153 ± 20.1 |
TG | 157 ± 78.5 | 148 ± 78.0 | 169 ± 82.2 | 140 ± 72.5 | 146 ± 61.8 | 147 ± 61.3 | 152 ± 65.3 | 142 ± 57.6 |
highTG | Control (TG ≤ 100, n=1914) | Case (TG ≥ 180, n=1779) | ||||||
Area/sex n=individual | Ansung n=920 | Ansan n=994 | Male n=700 | Female n=1214 | Ansung n=936 | Ansan n=843 | Male n=969 | Female n=810 |
LDL | 109 ± 29.7 | 118 ± 30.0 | 116 ± 31.9 | 112 ± 29.1 | 104 ± 33.7 | 122 ± 33.8 | 111 ± 35.8 | 115 ± 33.8 |
TG | 81.4 ± 13.6 | 80.4 ± 13.5 | 80.0 ± 14.8 | 81.5 ± 12.7 | 248 ± 55.5 | 241 ± 53.6 | 248 ± 56.1 | 240 ± 52.6 |